Skip to main content

HyperCas12a enables highly-multiplexed epigenome editing screens.

Publication ,  Journal Article
Melore, SM; Hamilton, MC; Reddy, TE
Published in: bioRxiv
July 9, 2024

Interactions between multiple genes or cis-regulatory elements (CREs) underlie a wide range of biological processes in both health and disease. High-throughput screens using dCas9 fused to epigenome editing domains have allowed researchers to assess the impact of activation or repression of both coding and non-coding genomic regions on a phenotype of interest, but assessment of genetic interactions between those elements has been limited to pairs. Here, we combine a hyper-efficient version of Lachnospiraceae bacterium dCas12a (dHyperLbCas12a) with RNA Polymerase II expression of long CRISPR RNA (crRNA) arrays to enable efficient highly-multiplexed epigenome editing. We demonstrate that this system is compatible with several activation and repression domains, including the P300 histone acetyltransferase domain and SIN3A interacting domain (SID). We also show that the dCas12a platform can perform simultaneous activation and repression using a single crRNA array via co-expression of multiple dCas12a orthologues. Lastly, demonstrate that the dCas12a system is highly effective for high-throughput screens. We use dHyperLbCas12a-KRAB and a ~19,000-member barcoded library of crRNA arrays containing six crRNAs each to dissect the independent and combinatorial contributions of CREs to the dose-dependent control of gene expression at a glucocorticoid-responsive locus. The tools and methods introduced here create new possibilities for highly multiplexed control of gene expression in a wide variety of biological systems.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

bioRxiv

DOI

EISSN

2692-8205

Publication Date

July 9, 2024

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Melore, S. M., Hamilton, M. C., & Reddy, T. E. (2024). HyperCas12a enables highly-multiplexed epigenome editing screens. BioRxiv. https://doi.org/10.1101/2024.07.08.602263
Melore, Schuyler M., Marisa C. Hamilton, and Timothy E. Reddy. “HyperCas12a enables highly-multiplexed epigenome editing screens.BioRxiv, July 9, 2024. https://doi.org/10.1101/2024.07.08.602263.
Melore SM, Hamilton MC, Reddy TE. HyperCas12a enables highly-multiplexed epigenome editing screens. bioRxiv. 2024 Jul 9;
Melore, Schuyler M., et al. “HyperCas12a enables highly-multiplexed epigenome editing screens.BioRxiv, July 2024. Pubmed, doi:10.1101/2024.07.08.602263.
Melore SM, Hamilton MC, Reddy TE. HyperCas12a enables highly-multiplexed epigenome editing screens. bioRxiv. 2024 Jul 9;

Published In

bioRxiv

DOI

EISSN

2692-8205

Publication Date

July 9, 2024

Location

United States